Personalized Medical Care & Dedicated International Patient Concierge
Anti-Aging Skin Boosters · Consultation Required
BNV Exo Mela-I
BNV Exo Mela-I is an advanced anti-AGE skin booster therapy formulated with a synergistic combination of growth factors, minerals, vitamins, and pyridoxine (vitamin B6), designed to address pigmentation disorders — including melasma and hyperpigmentation — while simultaneously improving.
Schedule a Consultation
# What Is BNV Exo Mela-I Anti-AGE Skin Booster Therapy?
BNV Exo Mela-I is an advanced anti-AGE skin booster therapy formulated with a synergistic combination of growth factors, minerals, vitamins, and pyridoxine (vitamin B6), designed to address pigmentation disorders — including melasma and hyperpigmentation — while simultaneously improving redness, skin sensitivity, and overall skin tone at a deeper dermal level.
Unlike conventional pigmentation treatments that focus exclusively on surface-level melanin correction, BNV Exo Mela-I works by restoring skin balance and improving cellular function from within the dermis. The multi-component formulation supports both pigment regulation and skin regeneration — addressing the underlying biological environment that sustains pigmentation disorders and contributes to chronic redness and uneven skin tone, rather than treating visible symptoms alone.
At Maylin Cheongdam, BNV Exo Mela-I is incorporated into personalized, comprehensive skin revitalization programs developed through detailed diagnostic assessment of each patient's skin condition, pigmentation profile, inflammatory status, and aging characteristics. Treatment protocols are designed under Dr. Hyun Jun Park's direct clinical oversight and may be combined with advanced dermatological laser systems or complementary skin booster and regenerative therapies where clinically appropriate — reflecting the clinic's precision-based, dual-layer approach to skin health and anti-aging medicine.
# Who Is a Good Candidate for BNV Exo Mela-I Melasma and Pigmentation Treatment?
BNV Exo Mela-I is well-suited for patients experiencing persistent pigmentation disorders, redness, or uneven skin tone who want a biologically active treatment that addresses both visible skin concerns and the underlying cellular conditions that sustain them. You may be an ideal candidate if you:
- Are in your late 20s to 60s and dealing with melasma, age spots, or hyperpigmentation that has not responded adequately to topical brightening treatments or conventional laser approaches alone
- Experience chronic facial redness or erythema alongside pigmentation concerns and want a treatment that addresses both conditions through a single, targeted formulation
- Have sensitive or reactive skin that limits tolerance for more aggressive laser or resurfacing procedures and requires a gentler, biologically supportive revitalization approach
- Notice uneven skin tone and complexion dullness that reflects underlying cellular aging and pigmentary dysregulation rather than surface concerns only
- Are managing hormonally influenced melasma and want a medically guided, multi-modal treatment strategy that complements laser or topical care
- Want a skin booster treatment that provides both pigmentation correction and broader skin revitalization benefits — including hydration, texture improvement, and cellular regeneration
- Are building a comprehensive anti-aging and skin health program and need an evidence-based foundational booster that targets pigmentation while supporting overall skin quality
- Prefer a minimally invasive, physician-supervised treatment with a transparent, structured clinical framework and realistic long-term skin improvement goals
A detailed consultation and skin diagnostic assessment at Maylin Cheongdam will confirm candidacy and allow the team to design a BNV Exo Mela-I protocol precisely matched to your skin's pigmentation profile, sensitivity, and revitalization needs.
# Meet the Specialist: Dr. Hyun Jun Park and the Maylin Cheongdam Team

Dr. Hyun Jun Park
Medical Director & Chief Director
Dr. Hyun Jun Park — Medical Director & Chief Director, Maylin Cheongdam M.D. | M.S. | Ph.D. Candidate in Anatomy, Gachon University College of Medicine
Dr. Hyun Jun Park leads Maylin Cheongdam's pigmentation management and skin revitalization programs with a clinical approach grounded in anatomical science, evidence-based dermatology, and a research-active academic career spanning more than a decade of clinical leadership. His ongoing doctoral training in anatomy at Gachon University College of Medicine provides scientific depth directly relevant to skin booster and injectable pigmentation treatments — where understanding dermal architecture, cellular biology, and the structural basis of pigmentary conditions is fundamental to designing protocols that achieve genuine biological improvement.
As former Chief Director of Maylin Apgujeong from 2009 to 2023, Academic Vice President of the Korean Society for Laser, Dermatology, and Hair Restoration (KSLDH), Vice President of ICLAS, Head of the Lifting Division at Meducation K, and Medical Advisor to Rejuran, Dr. Park brings exceptional breadth of clinical leadership and academic engagement to the fields of aesthetic dermatology and regenerative skin medicine. His authorship of more than 12 SCI-indexed publications ensures that every skin booster and pigmentation management protocol at Maylin Cheongdam is continuously informed by current evidence in skin biology, cellular aging, and advanced dermatological therapy.
The Maylin Cheongdam team is united by a shared clinical philosophy: that effective, lasting pigmentation management and skin revitalization require precise diagnosis, individually tailored treatment delivery, and a structured long-term approach to skin health — not isolated, surface-level correction applied without comprehensive clinical assessment.
# BNV Exo Mela-I Treatment Areas and Expected Improvements
BNV Exo Mela-I skin booster therapy at Maylin Cheongdam targets the following skin concerns and treatment zones:
- Melasma and Hyperpigmentation (Cheeks, Forehead, Upper Lip, Full Face): The growth factor and pyridoxine (vitamin B6) components of BNV Exo Mela-I work at a dermal level to support pigment regulation and reduce the cellular activity underlying melasma and hyperpigmentation. Unlike surface-only brightening treatments, this formulation addresses the biological environment sustaining pigmentary overactivity — supporting gradual, progressive improvement in patch intensity and overall tone uniformity. Individual outcomes depend on melasma type, hormonal influences, skin tone, and the number of treatment sessions completed.
- Facial Redness and Erythema (Cheeks, Nose, Forehead, Sensitive Zones): The anti-inflammatory and skin-calming properties of the BNV Exo Mela-I formulation help modulate chronic redness and erythema at a cellular level, supporting a more stable and resilient skin environment over time. For patients with concurrent pigmentation and redness concerns, the dual-action nature of the treatment provides a clinically meaningful advantage over single-target approaches. Improvement in redness is gradual and develops across a structured treatment series.
- Uneven Skin Tone and Complexion Clarity (Full Facial Surface): The synergistic vitamin, mineral, and growth factor complex supports improved cellular turnover and skin luminosity, progressively enhancing overall complexion clarity and tone evenness. Patients with chronically dull, uneven, or lacklustre skin often report this improvement in radiance and tone uniformity as one of the most noticeable early outcomes of BNV Exo Mela-I treatment, with results building cumulatively across sessions.
- Skin Hydration and Texture Enhancement (Full Face): Beyond pigmentation and redness correction, BNV Exo Mela-I contributes to improved skin hydration and surface texture — reflecting the formulation's broader revitalization properties. As the skin's internal moisture balance and cellular function are supported, surface quality progressively improves, resulting in a smoother, more resilient complexion. These texture and hydration improvements complement and reinforce the pigmentation management benefits of the treatment.
- Anti-AGE Cellular Revitalization and Long-Term Skin Health: As part of a structured anti-aging program at Maylin Cheongdam, BNV Exo Mela-I contributes to long-term cellular revitalization by supporting the skin's biological regenerative environment alongside targeted pigmentation correction. Patients pursuing sustained skin health rather than one-time cosmetic correction benefit from the treatment's dual role as both a pigmentation management tool and a broader anti-aging skin booster within a comprehensive, physician-supervised care program.
Results from BNV Exo Mela-I develop progressively and vary by individual skin condition, pigmentation type, degree of redness, and number of treatment sessions completed. No specific outcome is guaranteed, and a realistic, transparent treatment plan will be established during your initial consultation.
# The BNV Exo Mela-I Treatment Process at Maylin Cheongdam

1. Consultation and Diagnostic Skin Assessment: Your first appointment includes a thorough evaluation of your pigmentation distribution, redness profile, skin sensitivity, hydration levels, tone irregularities, and overall skin aging pattern using precision skin analysis systems and diagnostic imaging. This detailed assessment determines the most appropriate BNV Exo Mela-I delivery protocol and whether combination with laser or regenerative therapies is clinically indicated.
2. Personalized Treatment Protocol Design: Based on diagnostic findings, Dr. Park's team designs a BNV Exo Mela-I protocol specifying delivery method, targeted treatment zones, session frequency, and integration with any complementary dermatological laser or skin booster therapies. All protocol decisions are physician-led and individually justified based on your skin's specific pigmentation profile, inflammatory condition, and revitalization goals.
3. Pre-Treatment Preparation: The treatment area is cleansed and prepared according to Maylin Cheongdam's clinical protocol. Where indicated, a topical anesthetic may be applied to ensure patient comfort during the delivery process. The clinical team confirms all session parameters and aftercare instructions with the patient before proceeding.
4. BNV Exo Mela-I Delivery Session: The BNV Exo Mela-I formulation is administered through targeted skin delivery techniques using advanced skin booster delivery devices, allowing the growth factor, vitamin, mineral, and pyridoxine complex to penetrate effectively into the targeted dermal layers. Delivery parameters are adjusted throughout the session to ensure accurate and even coverage of the treatment zones. Sessions are generally efficient in duration and allow patients to return to daily activities with minimal disruption.
5. Immediate Post-Treatment Response and Aftercare: Mild redness, minor sensitivity, or slight swelling at the treatment site may occur immediately following the session and typically resolve within two to four days. The clinical team provides detailed aftercare instructions covering sun protection — particularly important for melasma-prone patients — skincare product restrictions, and activity guidance to protect and support the treatment's pigment-regulating and revitalization processes.
6. Progressive Results Timeline, Follow-Up, and Maintenance: Initial improvements in skin hydration, radiance, and surface redness may be perceptible within the first two to three weeks. Progressive improvement in pigmentation intensity, tone evenness, and skin clarity develops over four to eight weeks as the formulation's cellular effects accumulate across the dermis. Follow-up appointments allow the team to monitor pigmentation response, adjust the protocol where needed, and design a long-term maintenance program to sustain and build upon the skin health improvements achieved.
# BNV Exo Mela-I Results, Safety, and Longevity
- Results and Longevity: BNV Exo Mela-I delivers progressive, biologically grounded improvements in pigmentation, redness, and overall skin quality that develop cumulatively across a structured treatment course. Because the formulation addresses the underlying cellular environment sustaining pigmentation disorders rather than providing surface-only correction, results tend to be more durable and holistic than those achieved through conventional brightening treatments alone. Patients who complete a full treatment series, attend maintenance sessions, and follow strict sun protection guidance generally sustain meaningful improvements in skin tone clarity, pigmentation management, and overall skin health over an extended period. Longevity varies by pigmentation type, individual skin biology, hormonal factors, and environmental exposure.
- Safety Profile: BNV Exo Mela-I is administered at Maylin Cheongdam using medically verified formulations delivered through advanced skin booster delivery systems under the direct supervision of Dr. Hyun Jun Park. All treatment protocols are developed through detailed diagnostic assessment and adhere to the clinic's structured clinical framework — ensuring that delivery parameters, session frequency, and any combination therapy decisions are made with full consideration of each patient's skin condition, sensitivity, and therapeutic objectives. The clinic's emphasis on precision-based, physician-led care reflects its commitment to safety alongside clinical efficacy.
- Possible Side Effects: The most commonly reported post-treatment effects are mild redness, minor swelling, and temporary sensitivity at the delivery site — all of which are transient and typically resolve within a few days. Patients with highly sensitive or reactive skin may experience a slightly longer period of mild sensitivity following treatment. Sun exposure following pigmentation treatment should be strictly managed, as UV exposure is a primary driver of melasma recurrence and pigmentation persistence. Serious adverse events are rare but possible and are discussed in full transparency during your pre-treatment consultation. The Maylin Cheongdam clinical team monitors each patient's pigmentation and skin response throughout their treatment course, adjusting protocols where needed to ensure consistent safety and appropriate clinical progression.
# Why Choose Maylin Cheongdam for BNV Exo Mela-I Melasma and Skin Revitalization Treatment?

Maylin Cheongdam integrates BNV Exo Mela-I within a comprehensive, dual-layer anti-aging and dermatology framework in which pigmentation management is approached not as an isolated surface concern but as part of a broader strategy for long-term skin health and cellular revitalization. Every treatment protocol begins with a precision diagnostic assessment and is designed around the individual patient's pigmentation profile, inflammatory condition, and anti-aging goals — ensuring that the clinical intervention is genuinely matched to the biological complexity of the concern being treated.
The clinic's ability to combine BNV Exo Mela-I with advanced dermatological laser systems, regenerative therapy platforms, and complementary skin boosters means that patients with complex or treatment-resistant pigmentation concerns benefit from a truly integrative, multi-modal approach. Under Dr. Hyun Jun Park's clinical leadership and academic oversight, this combination capability is applied with the same level of scientific rigor and individualized judgment that defines every treatment program at Maylin Cheongdam.
- Synergistic multi-component formulation — growth factors, minerals, vitamins, and pyridoxine (vitamin B6) working in combination to address both pigmentation regulation and cellular skin revitalization at a deeper dermal level.
- Dual-target treatment approach — BNV Exo Mela-I simultaneously addresses melasma and hyperpigmentation alongside redness and erythema, providing a clinically meaningful advantage for patients with concurrent skin concerns.
- Integrated combination capability — BNV Exo Mela-I is coordinated with advanced laser systems and regenerative platforms where clinically appropriate, supporting more comprehensive and sustained pigmentation management outcomes.
- Precision-based, physician-led clinical planning — every treatment protocol is individually designed through detailed diagnostic assessment and administered within a structured, long-term skin health strategy under Dr. Park's direct supervision.
# What Patients Say About BNV Exo Mela-I at Maylin Cheongdam
## Patient Vignette — Melasma and Pigmentation Management, 40s
A patient in her early 40s had managed persistent melasma across her cheeks and forehead for several years, finding that topical treatments provided limited improvement and that previous laser sessions had produced inconsistent results. Following a personalized BNV Exo Mela-I treatment series at Maylin Cheongdam — integrated with a complementary laser protocol — she described a gradual but meaningful reduction in patch intensity and a noticeably more even complexion developing over her treatment course. She highlighted the clinical team's thorough assessment of her pigmentation type and the realistic, transparent expectations they established from the outset as important factors in her positive experience.
## Patient Vignette — Redness and Skin Tone Correction, Late 30s
A patient in her late 30s sought treatment for persistent facial redness and an uneven, dull complexion that had become increasingly prominent and affected her confidence. After a BNV Exo Mela-I skin booster series at Maylin Cheongdam, developed through a detailed skin diagnostic assessment, she reported a visible calming of chronic redness, improved skin radiance, and a more uniform complexion tone that developed progressively over the weeks following her treatment course. She appreciated the non-invasive nature of the procedure and the minimal disruption to her daily routine throughout the treatment period.
# Address Melasma, Pigmentation & Redness with BNV Exo Mela-I at Maylin Cheongdam
If persistent melasma, hyperpigmentation, chronic redness, or uneven skin tone are affecting your skin confidence and quality of life, Maylin Cheongdam's BNV Exo Mela-I Anti-AGE Skin Booster program offers the clinical precision and individualized care to support meaningful, progressive improvement. Dr. Hyun Jun Park and the Maylin Cheongdam team are committed to delivering pigmentation management and skin revitalization therapy that is biologically grounded, evidence-based, and structured around your individual skin profile and long-term skin health goals.
Contact our Dermatology and Anti-Aging Revitalization Medicine team to schedule your diagnostic skin assessment, discuss your pigmentation and skin tone concerns in detail, and receive a fully personalized BNV Exo Mela-I treatment plan. We welcome both local and international patients and provide comprehensive pre-treatment guidance, transparent clinical planning, and continuity of care throughout your skin revitalization journey.
Other Services
Explore additional treatments offered by our specialists.
Genesis Laser
Genesis Laser is a non-invasive skin rejuvenation treatment using a long-pulse 1064nm Nd:YAG laser to gently heat the dermis and stimulate natural collagen production.
Learn More
Ulthera
Ulthera (Ultherapy) is a non-invasive HIFU lifting procedure that uses High-Intensity Focused Ultrasound to target the deep structural layers of facial tissue — including the SMAS (superficial musculoaponeurotic system) layer, the same layer surgically addressed during a traditional.
Learn More
BNV Exo Mela-I
BNV Exo Mela-I is an advanced anti-AGE skin booster therapy formulated with a synergistic combination of growth factors, minerals, vitamins, and pyridoxine (vitamin B6), designed to address pigmentation disorders — including melasma and hyperpigmentation — while simultaneously improving.
Learn More